Expressing support for the designation of November as "Complex Regional Pain Syndrome and Reflex Sympathetic Dystrophy Syndrome Awareness Month".
Impact
The resolution underscores the importance of advancing medical research and treatment options for CRPS, which currently lacks an FDA-approved treatment. It highlights that efforts should be made to encourage accurate diagnosis and to create regulatory pathways conducive to drug development for this condition. By designating an awareness month, the bill seeks to foster an environment more supportive of research into CRPS, ultimately benefiting those affected by this debilitating condition.
Summary
House Resolution 903 expresses support for the designation of November as 'Complex Regional Pain Syndrome and Reflex Sympathetic Dystrophy Syndrome Awareness Month'. The resolution aims to raise awareness about Complex Regional Pain Syndrome (CRPS), a rare and poorly understood neuro-inflammatory condition characterized by severe chronic pain, swelling, and vascular changes. The bill emphasizes the critical need for increased recognition and understanding of CRPS, particularly regarding its symptoms and the challenges faced by patients in obtaining timely diagnoses and effective treatments.
Contention
While HR903 is largely a supportive measure, it may encounter challenges related to the prioritization of funding and resources for rare diseases like CRPS in the broader spectrum of healthcare. Advocates for patients argue that greater awareness could lead to improved research funding and access to treatment options, yet concerns remain about the extent to which such awareness campaigns will influence legislative and medical action in favor of CRPS patients.
Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September as "PCOS Awareness Month".
Expressing support for the designation of May 15, 2025, as "Prader-Willi Syndrome Awareness Day" to raise awareness of and promote research on the disorder.
A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2025 as "PCOS Awareness Month".